The most recent EPS for Shoulder Innovations Inc is $-0.38, beating expectations of $-0.33.
How did Shoulder Innovations Inc SI's revenue perform in the last quarter?
Shoulder Innovations Inc revenue for the last quarter is $-0.38
What is the revenue estimate for Shoulder Innovations Inc?
According to 7 of Wall street analyst, the revenue estimate of Shoulder Innovations Inc range from $17.23M to $14.99M
What's the earning quality score for Shoulder Innovations Inc?
Shoulder Innovations Inc has a earning quality score of B+/57.05758. The score is based on a four dimension of Profitability, Growth, Cash generation & Capital Allocation, and Leverage.
When does Shoulder Innovations Inc report earnings?
Shoulder Innovations Inc next earnings report is expected in 2026-06-08
What are Shoulder Innovations Inc's expected earnings?
Shoulder Innovations Inc expected earnings is $13.17M, according to wall-street analysts.
Did Shoulder Innovations Inc beat earnings expectations?
Shoulder Innovations Inc recent earnings of $14.41M beat expectations.
Key Stats
Prev.Close
$12.77
Open
$12.9
Day's Range
$12.27 - $13.32
52 week range
$10.92 - $17.94
Volume
59.7K
Avg.Volume
75.0K
Dividend yield
--
EPS (TTM)
-0.84
Market Cap
$272.5M
What is SI?
Shoulder Innovations Inc is a US-based company operating in industry. The company is headquartered in Grand Rapids, Michigan and currently employs 61 full-time employees. The company went IPO on 2025-07-31. Shoulder Innovations, Inc. is a commercial-stage medical technology company focused on transforming the shoulder surgical care market. The firm offers advanced implant systems for shoulder arthroplasty. These systems are a core element of its ecosystem, designed to improve the core components of shoulder surgical care, preoperative planning, implant design and procedural efficiency, to benefit each stakeholder in the care chain. Its ecosystem is also comprised of enabling technologies, instrument systems, specialized support and surgeon-to-surgeon collaboration. Its advanced implants are comprised of its aTSA and rTSA systems, which are designed to address the needs of patients and surgeons, and include various, specifically designed components capable of an array of system configurations to facilitate different modes of operation (anatomic or reverse). Its InSet Glenoid technology serves as the foundation for its advanced implant systems and includes a novel InSet design.